Report
Cheplapharm Arzneimittel : Issuance Focus
Eight months after its debut € 500m high-yield issuance, Cheplapharm is back on the market with a much larger € 1bn issue. The outstanding bond, which was very well received notably thanks to strong demand from German accounts, is down 3pts since issuance but has still outperformed the rest of the market and even other healthcare names. Cheplapharm has been barely if not at all affected by Covid-19 thanks to its strong supply chain, its diverse product range and geographic reach....
Provider
Oddo BHF
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Maxime Kogge
Other Reports from Oddo BHF
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.